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Abstract 
Human plasminogen activator inhibitor type 1 (PAI-1) is an important serpin that plays a 
role in the delicate balance between blood clot formation and fibrinolysis. Elevated PAI-1 levels 
correlate with many diseased states such as diabetes, heart disease, and arthrosclerosis. PAI-1 
functions to regulate plasminogen activation by inhibiting tissue-type and urokinase-type 
plasminogen activators, which are serine proteases that cleave the zymogen form to produce 
active plasmin. Its reactive center loop (RCL) binds the active sites of the target protease and 
inactivates its enzymatic function. From immobilized metal affinity chromatography, it was 
known that recombinant PAI-1 binds metals. This is relevant because metals have been 
demonstrated to play roles in inflammatory response, tumor progression, diabetes and other 
diseased states. Previous work has shown the effects of alkaline earth metals and transition 
metals in the absence and presence of cofactor Vitronectin.  We are currently exploring the use 
of a lanthanide called terbium (Tb) that has been used with calcium binding proteins to accept 
energy transferred from neighboring Tryptophan (Trp) residues. Native PAI-1 has four Trp 
residues located at positions 86, 139, 175, and 262 in the functional protein sequence. Previous 
investigation has shown the importance of the Trp side chains in kinetic stability of active PAI-1 
and has shown that the high quantum yield of W262 gives the greatest contribution to PAI-1 
fluorescence. Studies were conducted making steady state fluorescence measurements pertaining 
to both L-Trp and wild-type/mutant PAI-1 experimentation using Trp light emission as a donor 
for excitation of Tb as a Förster resonance energy transfer (FRET) acceptor in effort to obtain 
donor-acceptor interdistance information. The increase of fluorescence emission at 544 nm 
suggests that the metal and protein are indeed binding, and signal differences among the four Trp 
sites, of which the brightest W262 site is highlighted in this work, will be used to elucidate the 
approximate location of the transition metal binding site. 
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Introduction 
Human plasminogen activator inhibitor type 1 (PAI-1) is a serine protease inhibitor, or 
serpin, that plays an important role in hemostasis, the delicate balance between blood clot 
formation and fibrinolysis. PAI-1 enters the circulation by release from platelets, hepatocytes, 
and adipocytes as well as other kinds of cells. Diseased states like arthrosclerosis and severe 
sepsis exhibit marked inflammation with a dramatic increase in plasma concentrations of PAI-1, 
and there is positive correlation between high levels of PAI-1 and invasiveness of certain types 
of cancer.1  The PAI-1 serpin is comprised of 379 amino acids to produce a molecular weight of 
43 kilodaltons (kDa) in its recombinant form, or approximately 50 kDa in its glycosylated native 
form. This plasma glycoprotein regulates plasminogen activation by inhibiting tissue-type and 
urokinase-type serine proteases, through presentation of a solvent-exposed pseudosubstrate loop 
that effectively traps its bait protein. This reactive 
center loop (RCL) of PAI-1 initiates the suicidal 
behavior of the serpin as it binds the active site of 
the target protease, effectively inactivating the 
enzymatic function of the protease to generate 
active plasmin by cleaving plasminogen. This 
serpin is considered metastable, as PAI-1 
spontaneously transitions from an active to a latent 
conformation (Fig. 1) when the RCL inserts as a 
beta strand into the central beta sheet. The RCL’s 
mobility drives the conformational transitions. The activity of PAI-1 is typically measured by its 
ability to inhibit its target protease tPA over time. As PAI-1 transitions to the latent confirmation, 
there is less inhibition of target proteases and thus greater activity of tPA. The half-life of active 
PAI-1 under physiological conditions (pH 7.4 and 37°C) is about 1-2 hours. When associated 
with cofactor extracellular matrix protein vitronectin (VN) there is roughly a 50% increase in 
half-life.  
PAI-1 and VN exhibit low nanomolar affinity for complex formation (Fig. 2), and are 
both found in circulation and the extracellular matrix. Aside from stabilizing the active PAI-1 
Figure 1: The transition of PAI-1 from 
active to latent conformation. 
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conformation by binding at its Somatomedin B 
(SMB) interface and across an extended binding 
interface,2 VN appears to localize the complex 
to sites where inhibition of plasminogen 
activation is needed, such as the fibrin matrix of 
nascent blood clots. These proteins reside in the 
plasma and extracellular space where they 
function to inhibit fibrinolysis or extracellular 
proteolysis, control cell adhesion and migration, 
and assist in inflammatory response.  
From immobilized metal affinity chromatography (IMAC) purification it was known that 
recombinant PAI-1 binds metals, and the role of metals in PAI-1 is relevant because metals have 
been demonstrated to play a role in the severity of inflammatory response, tumor progression, 
diabetes, atherosclerosis, and neurological disease. According to the Protein Data Bank (PDB), 
about 40% of proteins contain metal cofactors that serve structural and/or functional capacities. 
Previous work in the Peterson Laboratory examined the effect of both alkaline earth metals (Mg, 
Ca, Mn) and some transition metals (Fe, Co, Ni, Cu) on the stability of PAI-1 in the absence and 
presence of cofactor VN.3 Metals were classified as oxygen seeking versus nitrogen/sulfur 
seeking. This facilitated division into Type I alkaline earth metals which tend to form ionic 
bonds and Type II transition metals which tend to 
have partially covalent bond character. As illustrated 
in Fig. 3, Type I metals (Mg, Ca, Mn) promoted a 10-
20 percent increase in PAI-1 stability, but no 
additional stabilization when PAI-1 was complexed 
with VN. In contrast, Type II (Cu, Ni, Co) metals had 
a dramatic destabilizing effect on PAI-1 alone and a 
stabilizing effect on the PAI-1: VN complex. For 
example, nickel produced a 40-fold change in the 
half-life of PAI-1 when assayed in the absence and 
presence of VN.  
Figure 2: PAI-1 and VN complex 
Figure 3: PAI-1 half-life in presence of 
metals (taken from [2]: Thompson et al, 
2011). 
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This investigation also established binding affinities of PAI-1 for the Type II metals 4 
using kinetic approach-to-equilibrium measurements of intrinsic tryptophan (Trp or W) 
fluorescence shifts upon metal binding to PAI-1, which contains four Trp residues. These 
included a first exponential corresponding to the metal-binding event, along with two more 
exponentials thought to represent ensuing 
conformational change of the metal-bound 
protein. However, more recent work in the 
Peterson Lab revealed that some of the Type II 
metals interact directly with tryptophan (L-Trp) 
in its free amino acid form (Fig. 4), resulting in 
quenched fluorescence of the indole side chain. 
The study now includes zinc, which competes 
with the interfering metals to restore quenched 
L-Trp fluorescence. This post-transition metal 
also causes rapid destabilization of active PAI-1, consistent with results from copper, the highest 
affinity ligand among the Type II metals tested. Due to the low solubility of zinc, glycine has 
been employed as a bioavailable chelator to assist dissolution. The presence of this additional 
component creates uncertainty for actual free metal calculations and produces some fluorescence 
measurement artifacts. Therefore, we are currently exploring the use of an optically active 
lanthanide called terbium (Tb) that has historically been used with calcium binding proteins to 
accept energy transferred from neighboring Trp residues using excitation light (295 nm) outside 
the Tyr range and exclusive to the Trp range.5 This phenomenon is called Förster resonance 
energy transfer (FRET), and if pilot studies with wild-type PAI-1 protein prove fruitful, then we 
will expand our work with Tb to include the four mutant PAI-1 proteins that each contain only a 
single Trp residue in effort to determine their individual proximities to the putative metal binding 
site.  
Native PAI-1 has four Trp residues located at positions 86, 139, 175, and 262 (Fig. 5). 
Based on work by another group,6 the Peterson Lab has generated mutant PAI-1 proteins that 
contain a single Trp site, wherein the other three residues are conservatively mutated to 
phenylalanine (Phe or F). Phe was chosen to replace Trp because both are aromatic, and the 
remaining aromatic residue, tyrosine (Tyr or Y), could interfere with fluorescence measurements 
Figure 4: Some Type II metals quench 
intrinsic Trp fluorescence. 
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despite using excitation wavelength of 295 nm. Their 
investigation showed the importance of the Trp side chains in 
kinetic stability of active PAI-1 and showed that the high quantum 
yield of W262 gives the greatest contribution to PAI-1 
fluorescence. In the wild-type protein, fluorescence of this residue 
is likely quenched by energy transfer to residue 175, as its overall 
signal is lower than that of the “W262-Only” (W86-139-175F) 
mutant. In general, the three W262F mutants (W86-Only, W139-
Only, and W175-Only) have lower quantum yields relative to 
wild-type PAI-1. Compared to wild-type PAI-1, all the triple 
mutants containing W262F have ~20 min half-lives, while the 
W262-Only mutant has 5 hour half-life reminiscent of the W175F 
mutant.7 Manipulation of the W175 site profoundly influences RCL movement, including the 
insertion of the N-terminal portion of the RCL into beta-sheet A during latency transition. 
Spectral isolation of the individual Trp sites should allow us to gain perspective on the 
metal binding conformational changes reported by each location. Therefore, studies were 
conducted on four Trp mutants, with an emphasis on investigation of the W262-Only mutant, 
using Tb as a FRET acceptor for selectively excited Trp fluorescence emissions.  
Materials and Methods 
These experiments focused on the interaction of PAI-1 with Terbium metal. To facilitate 
the experiments, mutant strains of PAI-1 isolating 86, 139, 175, and 262 were needed. E. coli 
Rosetta 2 (DE3) pLysS cells (Novagen) were used in this study because they have been 
optimized for recombinant protein expression and have a quick doubling time of 45 minutes. 
Competent cells were stored in CaCl2 solution inside the -80°C freezer. The standard 
transformation reaction required 20 µL cells. Cells were removed from freezer and allowed to 
thaw while immersed in ice for a few minutes. Visual examination was used to make sure they 
had thawed, and tubes were finger-tapped to resuspend cells. Plasmid DNA amounting to 100 
nanograms was added to 50 µL of the competent cell tubes, and the tubes were allowed to sit on 
ice for 30 minutes. To trap the plasmids inside the cells, the tubes were heated for 30 to 90 
seconds at 42°C in a water bath to activate housekeeping genes. This is known as the heat shock 
Figure 5: Trp sites in PAI-1 
(structure image taken 
from Verheyden et al, 
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step. Then the tubes were cooled on ice for another two minutes. Then 500 µL of super optimal 
broth with catabolite repression (SOC) media was added to each tube. This was followed by 
growth in optimal conditions (37°C and shaking at 250 rpm) for two hours. Tubes were then 
centrifuged for five minutes at 14,000 x g, and 400 µL of supernatant was removed leaving 100 
µL for plating. Cell suspensions were then smeared on plates with antibiotics to select for the 
transformed cells. Plating involved immersing the plate spreader (bent glass rod) into ethanol and 
flaming for sterilization. The spreader was allowed to cool, and then cells were spread evenly 
across the plate with making sure to use gentle contact with plate. Plates were then incubated at 
37°C overnight with the cover-side down. 
Starter cultures were formed either from plates or from glycerol stocks that were kept in 
the -80°C freezer. If a glycerol stock was being used, then a sterile pipet tip was simply inserted 
into the frozen stock and some of the stock would adhere to the tip. The tip would then be ejected 
into a sterile conical flask with 15 mL of terrific broth. If the cells from the plates were being 
used, then an inoculation loop was used to pick off a colony from the plate, and the rod could 
then be submerged into the broth. The broth was always treated with antibiotics, specifically 15 
µL of Chloramphenicol (CAM) and 15 µL of Kanamycin (KAN). 
After 1 hour of incubation at optimal conditions, the starter culture was subcultured into 
one liter flasks and brought down to an optical density (OD) at 600 nm of 0.02. Growth in the 
one liter flasks was controlled in an incubator shaking at 250 rpm. When an OD600 of 1.2-1.5 was 
reached, cells were cooled to 15°C for equilibration. After approximately one hour, OD600 would 
reach 2-2.3 and expression could be induced. Induction was accomplished by adding 10 µL of 
IPTG to each one liter flask. Cells were then left to incubate overnight at 15°C (approximately 
16-18 hours) and were harvested the following morning. Cell harvest was completed by 30 
minutes of centrifugation at 4°C and 10,000 x g, 
followed by freezing of cell pellets at -80°C.  
To make sure that PAI-1 expression was 
being induced (Fig. 6), samples were analyzed by 
sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were 
Figure 6: Induction of PAI-1 protein 
expression (image credit: REU student 
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denatured by boiling with SDS and reducing 
sample dye. Wells were loaded with ladder in 
the first lane and samples in subsequent lanes, 
and gels were run at 150 volts for 70 minutes. 
Transfer to nitrocellulose membrane for 
“Western blotting” was begun by placing the 
gel and nitrocellulose sheet in between two 
foam pieces wet with conductive transfer buffer 
and running for 10 minutes at 15 volts. To block the membrane from nonspecific binding, it was 
incubated for one hour at room temperature shaking in 10% milk. This was followed by addition 
of primary antibody (usually rabbit antihuman PAI-1), and the membrane was allowed to 
incubate for two hours. Then the secondary antibody was added (usually peroxidase labeled anti-
rabbit), and the membrane was incubated for one hour shaking at room temperature. The 
membrane was washed three times with phosphate buffered saline (PBS) containing Tween in 
between blocking, primary antibody addition, and secondary antibody addition.  To develop the 
Western: 30 mL of 1x Pbs, 5 mL of 4-chloro-1-napthol, and 50 µL of 30% hydrogen peroxide 
were added to the membrane. The partially-transferred gel was stained in Coomassie Blue and 
then destained overnight. 
The harvested cells were lysed (Fisher Scientific 550 Sonicator Dismembrator), and PAI-
1 was purified using an EDTA-free purification protocol that included Chelex-treated buffers. 
The lysate was centrifuged at 10,000 x g for 30 min at 4°C. The supernatant was then loaded on 
SP-Sepharose cation exchange column at 10 mL/min and flow thru was collected. Elution was 
done by using a linear 80-500 mM (NH4)2SO4 gradient to gradually disrupt ionic interactions. 
During the protein elution, we collected one minute fractions at 10 mL/min, and read the 
absorbance at 280 nm (A280) fractions and plotted elution versus absorbance to make the elution 
profile. The samples collected from supernatant, flow thru, and wash were analyzed by SDS-
PAGE and Western blot. The pool was then transferred to dialysis membrane tubing (molecular 
weight cutoff 12-14,000 Da) and dialyzed against 4 L of imidazole buffer overnight at 4°C. The 
next day IMAC was utilized by charging a Chelating Sepharose column with 0.2 M NiSO4 
flowing long enough to allow nickel to bind the column, and excess nickel was removed with the 
wash buffer. Dialyzed protein was loaded onto Ni2+ Sepharose column. Then we washed with 
Figure 7: Purified PAI-1 proteins analyzed 
by SDS-PAGE and Western immunoblot.   
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imidazole buffer and applied an imidazole gradient to compete with histidine binding for release 
of bound proteins. The fractions were read to create and elution profile, and we analyzed by 
SDS-PAGE and Western blot. The protein was then concentrated to 2-3 milliliters volume and 
loaded on S-100 filtration column for fraction collection overnight. This was followed by reading 
fractions and making an elution profile. The PAI-1 peak fractions were pooled and 100 µL 
aliquots were stored in -80°C freezer until use. Proteins were analyzed for purity by SDS-PAGE 
and identity of PAI-1 proteins was confirmed by Western blot. Mutants were assayed for tPA-
binding activity. 
To measure protein concentration we used the bicinchoninic acid (BCA) protein assay. 
We prepared the BCA Working Reagent (WR) by using a formulate to determine the total of 
volume of WR needed in order to add 2 mL to each sample, and then preparing the WR by 
mixing 50 parts of BCA Reagent A with 1 part of BCA Reagent B. We used the standard 
protocol for the test-tube procedure. This begins with pipetting 0.1 mL of each standard and 
unknown sample replicate to each tube, then adding 2.0 mL of the WR to each tube and mixing. 
The tubes are then incubated at 37°C for 30 minutes in a water bath, and then cooled to room 
temperature. Then we measured absorbance at 562 nm, and we were able to the make a standard 
curve by plotting the measurements against concentration (µg/mL) after subtracting the 
absorbance measurement of the blank.   
To investigate metal binding to our protein and detect changes in affinity and enthalpy, 
we used a technique called isothermal titration calorimetry (ITC). We ran our protein through a 
desalting PD-10 column to remove any EDTA and phosphate. We began by running 40 mL of 50 
mM MOPS, 100 mM (NH4)2SO4 buffer through the PD-10 column, and then we ran the protein 
through the column in 2.5 mL of buffer. We then placed the protein in a dialysis cassette and 
placed the cassette in the ITC buffer, and we allowed it to stir in the cold room overnight. After 
extracting the protein solution and adding the metal to it, we made sure to keep our solution at a 
pH of 7.4. We could now take it to the calorimeter. The calorimeter contains a reference cell and 
an experimental cell, and we began by degassing all solutions and placing degassed deionized 
water in the experimental cell. We rinsed the cell several times with water and then buffer, and 
we added our ligand and protein solutions into the instrument. Finally, the experimental titration 
was started and the data was collected at 10°C 
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Using a PTI fluorometer, we tested the transmission of single Trp PAI-1 mutants W86-
Only, W139-Only, W175-Only, and W262-Only to the FRET donor Tb(III). With excitation slit 
width set to 8 nm, emission scans were completed with the wavelength range of 310 to 360 nm 
(range of FRET donor Trp) using a 2 nm slit width, and 520 to 570 nm (range of FRET acceptor 
Tb) using a 12 nm slit width. Using quartz cuvettes we produced 2 mL solution with the 
concentrations of 100 mM MOPS, 50 µM TbCl3, and a relevant concentration of the PAI-1 
mutant. Before taking measurements, we inserted a glass panel between the sample and detector 
to eliminate the transmission of excitation wavelength scattering. Our first measurement was 
without Tb, followed by a zero time point with 50 µM Tb, followed by measurements at 5-10 
minute intervals until 30 minutes were complete. With each mutant we obtained thirty minutes of 
data for each of four increasing concentrations (250, 500, 750, 1000 nM) of protein.  
Results and Discussion 
These studies were conducted with the goal of obtaining more information about the 
metal binding location within PAI-1 as reported by the four Trp sites shown in Fig. 5. To obtain 
site-specific results, mutants were generated to isolate the spectral properties of each Trp residue. 
Plasmids were successfully produced for each mutant such that the other three Trp sites were 
genetically altered to encode Phe, leaving only a single Trp in the mutants known as W86-Only, 
W139-Only, W175-Only, and W262-Only. We can see 
positive mutant expression in Fig. 6 as indicated by the 
bands by SDS-PAGE, and after protein purification the 
identities were confirmed as PAI-1 by Western blot (Fig. 
7). Using ITC we tested the mutant PAI-1 protein W262-
Only (Fig. 8) to confirm that mutagenesis did not alter 
metal-binding properties. According to a one-site binding 
fit of the data, the W262-Only PAI-1 protein (Kd ~ 10 
nM) showed a modest increase in the apparent affinity for 
copper relative to results obtained for wild-type PAI-1 (Kd 
~ 22 nM). This may be within experimental variation for 
ITC measurements, especially given the sensitivity of the 
technique to any change in protein concentration. Because 
Figure 8: ITC plot for W262-Only 
PAI-1 titrating copper sulfate. 
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the concentration of the Trp mutants cannot be reliably determined by spectrophotometric 
absorbance at 280 nm due to differences in quantum yield among individual sites,6 they must be 
BCA assayed for measurement accuracy. Since the protein solution was subjected to dialysis to 
exactly match the buffer used for titrating copper, a slight dilution could have occurred that 
would alter the numbers generated while fitting the ITC data points. Additionally, there is an 
artifact in the ITC data (after the sigmoidal enthalpic shift) as the instrument overshot the 
baseline while regaining temperature equilibrium, so a repeat measurement is warranted to verify 
the result. Regardless of the specific details, the plot shows that the mutant binds copper, which 
was the verifiable goal of the measurement.     
Terbium has been used to map calcium 
binding sites because of its similar ionic radius and 
metal coordination chemistry.5 While transition 
metals display variable physical features, it was 
confirmed with stopped-flow fluorometry that the 
conformational change reported by W262-Only 
looks similar to the response evoked by zinc (data 
not shown). Fluorescence resonance energy 
transfer can be utilized to determine distance of the 
transition metal binding site from individual Trp 
sites in PAI-1 because of energy transfer from the aromatic residues to the bound terbium ions. 
Signal differences among the four Trp sites can be used to elucidate the location of the transition 
metal binding site. One caveat to this assertion is the aforementioned fact that each Trp residue 
contributes a different amount of light, so the resulting changes in terbium fluorescence should 
be viewed through this prism. As shown in Fig. 9, a 30 µM Tb(III) solution was used with 
increasing W262-Only concentrations from 250 nM to 1000 nM. Excitation wavelength was set 
to 295 nm to selectively activate Trp sites and avoid confounding data with Tyr signals. Each 
data point in the figure is an average of the fluorescence measurements taken over 30 minutes. 
The increase of fluorescence emission at 544 nm suggests that the metal is indeed binding to the 
protein, with the nearby Trp residue transmitting light to increase the Tb signal. It is important to 
note that the W262-Only site is the most buried from solvent within the core of the folded 
protein, yet it exhibits the highest quantum yield of emitted light relative to the other three sites. 
Figure 9: Terbium fluorescence changes 
with increasing concentration of W262-
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For comparison, Fig. 10 shows 
relative changes for all of the PAI-1 
protein constructs after an hour-long 
incubation with 50 µM Tb(III). At first 
glance, the W262-Only mutant looks 
most interesting as the protein 
undergoing the biggest change in 
fluorescence when more protein is 
available to bind the terbium. 
However, it is unclear whether this 
trend will be upheld after data 
correction to include provision for differences in quantum yield. For instance, the slope of the 
W175-Only mutant data is comparable to that of the W262-Only mutant, and factoring in the 
lower brightness of the W175 site, the overall trend may become more dramatic after correction 
treatment. Interestingly, the W175 and W262 sites are located near the same “top” pole of the 
protein close to the RCL, while the W139 site is located near the “bottom” pole within the SMB 
domain and the highly solvent-exposed W86 site is situated in between the two extremes. 
Perhaps this data is suggesting the metal binding site is close to the top end of PAI-1, but further 
investigation will certainly be required to answer that hypothesis.  
Conclusion 
We effectively generated and investigated the W262-Only PAI-1 mutant using a 
combination of techniques from molecular biology and protein biochemistry to isothermal 
binding kinetics and intrinsic tryptophan fluorescence in order to better understand its metal 
interaction properties. Our focus on the W262-Only mutant is only one piece of the puzzle; 
however, more work remains to be completed in order to successfully elucidate the location of 
the transition metal binding site on the PAI-1 structure. When further analysis is completed on 
the other three mutants, more critical steps will have been taken toward the characterization of 
the putative metal binding site within this important therapeutic target for inflammatory disease.  
Figure 10: Linear changes in terbium fluorescence with 
increasing concentration of PAI-1 protein constructs.  
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